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Abstract BACKGROUND: Angiogenesis is a basic process that enables neoplasms to thrive. 
Microvessel density (MVD) evaluation is an accepted parameter for assessing the 
angiogenesis process within a tumor. The aim of the present study has been to 
assess the number of microcapillaries in both invasive ductal breast cancer with 
the presence of metastases in regional lymph nodes and in invasive ductal breast 
cancer without such metastases. 
METHODS: The CD34 antigen immunoreactivity level was assessed by immuno-
histochemistry in both types of invasive ductal breast cancer. Tissue samples were 
obtained from 40 patients and were divided into two groups according to whether 
or not there were lymph node metastases. 
RESULTS: The patients with lymph node metastases exhibited statistically signifi-
cantly higher numbers of stained microcapillaries than the patients who did not 
have lymph node metastases. 
CONCLUSION: Thus the number of stained microcapillaries as evaluated by using 
the CD34 immunoreactivity level seems to be a useful predictor for the develop-
ment of local lymph node metastases in female invasive ductal breast cancer.  
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INTRoDuCTIoN
Angiogenesis is a basic process that enables neoplasms 
to thrive [1]. Microvessel density (MVD) evaluation 
is an accepted parameter for assessing the angiogene-
sis process within a tumor. MVD can be immunohis-
tochemically evaluated by using anti-CD34 antibodies. 
The CD34 antigen is a membrane glycoprotein ex-
pressed by myeloid precursor cells and by small vessel 
endothelial cells [2]. In ductal in situ breast carcinoma 
a correlation has been found between MVD and local 
tumor invasion [3]. Normal glandular breast tissue is 
typified by lower MVD than DCIS whereas invasive 
ductal breast cancer is typified by higher MVD than 
DCIS [4]. A connection between the CD34 immuno-
reactivity level and a poor prognosis for a case has been 
established [5]. The presence of lymph node metasta-
ses is also a poor prognostic factor. The evaluation of 
MVD using the CD34 antigen immunoreactivity level 
in male breast cancer has not revealed any relationship 
between MVD and the presence of local lymph node 
metastases [6]. Such a relationship has, however, been 
demonstrated in both uterine cervical carcinoma and 
laryngeal cancer [7, 8].
The aim of the present study has been to assess the 
number of microcapillaries in invasive ductal breast 
cancer with the presence of metastases in regional 
lymph nodes and in invasive ductal breast cancer where 
there are no such metastases. 
MATeRIAL AND MeThoDS
2.1. The subjects
The informed consent of each patient for the use of pla-
cental tissue was obtained. Additionally, the approval of 
the Ethical Committee of the Jagiellonian University in 
Krakow (KBET/379/13/2003) was granted for this re-
search program. The patients in this study were ran-
domly selected. The surgically removed material was 
evaluated to determine the histological type and me-
tastases of the lymph nodes using histological methods 
in the Department of Pathomorphology of the Jagiel-
lonian University. We assessed the total immunoreac-
tivity of the CD34 antigen level in 40 breast cancer tis-
sue specimens. The women from whom the specimens 
were obtained ranged in age from 44 to 68 years (mean 
age, 49 years). All the women had undergone mastec-
tomies with axillary lymphadenectomies in the 1st De-
partment of General Surgery of the Jagiellonian Uni-
versity. Invasive carcinoma was a dominant component 
in each case. The surgically removed material was fixed 
in a 10% buffered formalin. The tissue was then em-
bedded in paraffin and stained with hematoxylin and 
eosin. Each specimen was inspected in order to meas-
ure tumor size and a number of lymph nodes was ob-
tained for further study. Microscopic examination was 
performed to identify the histological type and grade 
of invasive carcinoma, the presence of vessel invasion, 
and tumor metastases to the lymph nodes. Histological 
grades of invasive carcinoma were diagnosed according 
to the Bloom and Richardson classification modified by 
Elston and Ellis and recommended by the National Co-
ordinating Group for Breast Pathology [9]. 
2.2. Immunohistochemical staining and analysis of CD34 
antigen level.
Immunohistochemistry was carried out in paraffin-em-
bedded specimens of representative malignant tumor 
tissue fixed in a 10% butter formalin. For the purpose 
of endothelial cell visualization, anti-CD-34 monoclo-
nal antibodies (DAKO) at 1:25 dilution were added and 
incubated for 30 minutes at room temperature. Micro-
scopic analysis of immunohistochemically stained tis-
sue specimens was performed by light microscope. At 
40x magnification, the tumor regions with the highest 
Table 1. The number of stained microcapillaries relevant 
to histological grades according to Bloom and Richardson 
classification in 40 patients with invasive ductal breast cancer.
G1 (n=10) G2 (n=15) G3 (n=15)
Average number of 
microcapillaries 63.1 59.93 57.26
Standard deviation 33.26 25.85 37.09
with the presence of lymph 
node metastases
without the presence of 
lymph node metastases
Fig. 1. 
Figure 1. The number of stained microcapillaries 
in the patients with and without the presence 
of lymph node metastases (** p<0.05).
445Neuroendocrinology Letters Vol. 29 No. 4 2008 • Article available online: http://node.nel.edu
The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases
Figure 2. Immunoreactivity of the CD34 antigen level in invasive ductal breast cancer 
without lymph node metastases
1
Fig. 2. 
2
Fig. 3. 
Figure 3. Immunoreactivity of the CD34 antigen level in invasive ductal breast cancer 
with lymph node metastases
numbers of stained microcapillaries were chosen. Each 
time the number of microcapillaries in 10 randomly 
chosen fields was evaluated. Every stained endothelial 
cell or group of cells separated from adjacent tumor 
cells or elements of soft tissue was treated as a separate, 
single vessel; however, the existence (or absence) of an 
aperture in the examined capillary was not considered. 
2.3 Statistical analysis
The distribution of variables in the study groups of 
women checked with the use of the Shapiro-Wilk test 
showed that all of them were different from normal. 
Therefore, nonparametric testing was employed. The 
statistical significance between the groups was de-
termined by the Kruskal-Wallis analysis of variance 
(ANOVA) test. The Mann-Whitney U test was then 
used as applicable. 
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ReSuLTS
The presence of the CD34 antigen was identified in 
all tissue samples derived from patients with invasive 
ductal breast cancer. The patients were divided into 
two main groups according to whether or not they suf-
fered from lymph node metastases. The patients with 
lymph node metastases had statistically significantly 
lower breast cancer cell differentiation according to the 
Bloom scale when compared to those patients without 
metastases (p=0.03). We did not observe any statisti-
cally significant differences in clinical parameters (av-
erage age, body mass index, etc.) among the groups ex-
amined, and this fact enabled us to compare the CD34 
immunoreactivity level in the groups.
The number of stained microcapillaries was ana-
lyzed with respect to histological grades according 
to the Bloom and Richardson classification, and no 
statistically significant differences were observed be-
tween the analyzed subgroups (G1,G2,G3) of patients 
(Table 1).
Statistically significantly higher numbers of stained 
microcapillaries were observed in patients with lymph 
node metastases when compared to the numbers in 
patients without metastases (p=0.02) (Figure 1).
DISCuSSIoN
In our study, the patients with the presence of lymph 
node metastases exhibited statistically significantly 
higher numbers of stained microcapillaries than the 
patients without lymph node metastases (Figure 2, Fig-
ure 3). The relationship between the presence of lymph 
node metastases and an increase in MVD within the 
tumor has been confirmed in cervical, laryngeal, and 
gastric cancers [7,8,10]. No relationship between the 
presence of lymph node metastases and an increase in 
MVD has been established in cases of male breast can-
cer [6]. In female invasive ductal breast cancer, howev-
er, an increase in MVD has been correlated with a poor 
prognosis [11], and this would seem to confirm the re-
sults obtained in the present study. Bono et al. have ob-
served that an increase in lymphatic vessel density in 
the tumor microenvironment correlates with breast 
cancer progression [5]. The absence of the CD44 an-
tigen that typifies the increase in microvessel density 
in tumor cells has also been found in cases with lymph 
node metastases [12]. Similarly, microvessel quantity 
by factor VIII-related antigen staining has been shown 
to be higher in cases with lymph node metastases than 
those without [11].
The present study has had certain apparent limita-
tions. First, the limited number of patients included did 
not allow us to evaluate the influence of other factors 
on prognosis. Second, the immunohistochemistry tech-
nique introduced a degree of subjectivity. We reduced 
the impact of these problems by comparing the patients 
on whom one of two types of surgical procedures were 
performed, and the patients in each group did not dif-
fer with respect to clinical parameters. The possibility 
of subjectivity entering into the immunohistochemistry 
assessment was diminished by having two independent 
pathologists evaluate the tissue slides.
CoNCLuSIoN
The number of stained microcapillaries as evaluated by 
the CD34 immunoreactivity level seems to be a useful 
predictor for the development of local lymph node me-
tastases in female invasive ductal breast cancer. 
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